MAI Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Buy
247,151
+23,390
+10% +$1.34M 0.05% 270
2026
Q1
$13.6M Buy
223,761
+25,587
+13% +$1.49M 0.08% 228
2025
Q4
$10.7M Buy
198,174
+21,672
+12% +$1.04M 0.06% 257
2025
Q3
$7.96M Buy
176,502
+15,703
+10% +$733K 0.05% 292
2025
Q2
$7.44M Sell
160,799
-8,803
-5% -$432K 0.05% 280
2025
Q1
$10.3M Sell
169,602
-4,262
-2% -$248K 0.08% 214
2024
Q4
$9.83M Buy
173,864
+57,178
+49% +$3.19M 0.07% 222
2024
Q3
$6.04M Sell
116,686
-26,254
-18% -$1.23M 0.06% 228
2024
Q2
$5.94M Sell
142,940
-466,327
-77% -$20.9M 0.06% 236
2024
Q1
$33M Buy
609,267
+37,626
+7% +$1.92M 0.34% 63
2023
Q4
$29.3M Buy
571,641
+50,796
+10% +$2.67M 0.39% 56
2023
Q3
$30.2M Sell
520,845
-13,983
-3% -$857K 0.45% 53
2023
Q2
$34.2M Buy
534,828
+1,556
+0.3% +$104K 0.5% 52
2023
Q1
$37M Sell
533,272
-11,323
-2% -$799K 0.58% 40
2022
Q4
$39.2M Buy
544,595
+20,373
+4% +$1.54M 0.66% 37
2022
Q3
$37.3M Buy
524,222
+80,861
+18% +$5.87M 0.7% 31
2022
Q2
$34.1M Buy
443,361
+66,461
+18% +$5.06M 0.65% 36
2022
Q1
$27.5M Buy
376,900
+100,915
+37% +$6.78M 0.46% 57
2021
Q4
$17.2M Buy
275,985
+62,972
+30% +$3.69M 0.28% 87
2021
Q3
$12.6M Buy
213,013
+13,931
+7% +$917K 0.24% 95
2021
Q2
$13.3M Buy
199,082
+6,581
+3% +$429K 0.26% 92
2021
Q1
$12.2M Buy
192,501
+5,758
+3% +$358K 0.27% 90
2020
Q4
$11.6M Sell
186,743
-160,922
-46% -$9.9M 0.29% 84
2020
Q3
$21M Buy
347,665
+8,240
+2% +$496K 0.61% 42
2020
Q2
$20M Buy
339,425
+189,246
+126% +$11.3M 0.63% 42
2020
Q1
$8.37M Buy
150,179
+60,180
+67% +$3.68M 0.34% 68
2019
Q4
$5.78M Buy
89,999
+27,512
+44% +$1.58M 0.19% 104
2019
Q3
$3.17M Sell
62,487
-18,321
-23% -$861K 0.14% 130
2019
Q2
$3.67M Sell
80,808
-58,650
-42% -$2.73M 0.17% 127
2019
Q1
$6.65M Buy
139,458
+9,270
+7% +$462K 0.34% 81
2018
Q4
$6.77M Buy
130,188
+5,269
+4% +$283K 0.39% 72
2018
Q3
$7.75M Sell
124,919
-343
-0.3% -$20.4K 0.4% 74
2018
Q2
$6.93M Buy
125,262
+1,180
+1% +$63.7K 0.37% 81
2018
Q1
$7.85M Buy
124,082
+900
+0.7% +$57.9K 0.45% 65
2017
Q4
$7.55M Sell
123,182
-6,986
-5% -$437K 0.43% 70
2017
Q3
$8.3M Sell
130,168
-1,524
-1% -$89K 0.5% 58
2017
Q2
$7.34M Buy
131,692
+9,035
+7% +$492K 0.47% 63
2017
Q1
$6.67M Buy
122,657
+114,533
+1,410% +$6.28M 0.45% 65
2016
Q4
$475K Sell
8,124
-1,001
-11% -$54.7K 0.03% 265
2016
Q3
$492K Sell
9,125
-9,123
-50% -$586K 0.04% 273
2016
Q2
$1.34M Sell
18,248
-884
-5% -$62.5K 0.1% 151
2016
Q1
$1.22M Sell
19,132
-106
-0.6% -$6.68K 0.09% 158
2015
Q4
$1.32M Buy
19,238
+734
+4% +$48.5K 0.1% 154
2015
Q3
$1.09M Buy
18,504
+314
+2% +$19.9K 0.08% 182
2015
Q2
$1.21M Buy
18,190
+941
+5% +$62K 0.08% 189
2015
Q1
$1.11M Buy
17,249
+3,728
+28% +$233K 0.07% 193
2014
Q4
$798K Buy
13,521
+2,806
+26% +$158K 0.06% 228
2014
Q3
$548K Sell
10,715
-2,250
-17% -$112K 0.05% 240
2014
Q2
$629K Sell
12,965
-4,615
-26% -$227K 0.06% 208
2014
Q1
$913K Sell
17,580
-57
-0.3% -$3.03K 0.09% 150
2013
Q4
$937K Sell
17,637
-1,315
-7% -$67K 0.1% 149
2013
Q3
$877K Sell
18,952
-435
-2% -$19.1K 0.11% 132
2013
Q2
$866K Buy
+19,387
New +$842K 0.11% 130

Other funds holding BMY

MAI Capital Management's BMY Position: Q2 2026 in Review

MAI Capital Management increased its Bristol-Myers Squibb (BMY) stake by 10% in Q2 2026, buying an estimated $1.34M and bringing the position to 247,151 shares worth $14.2M. The position accounts for 0.05% of the portfolio, ranked #270.

MAI Capital Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $39.2M in Q4 2022. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • MAI Capital Management held 247,151 shares of Bristol-Myers Squibb worth $14.2M as of Q2 2026.
  • MAI Capital Management bought 23,390 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.34M.
  • Bristol-Myers Squibb made up 0.05% of MAI Capital Management's portfolio in Q2 2026, its #270 holding.
  • MAI Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • MAI Capital Management's Bristol-Myers Squibb position peaked at $39.2M in Q4 2022.
  • 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.